Michael Polansky is training an AI model on skin that’s still alive

Michael Polansky, known for his relationship with Lady Gaga and his role as a former senior advisor to Napster co-founder Sean Parker, has revealed a cutting-edge venture that applies artificial intelligence to unprecedented biomedical applications. His startup maintains viable human skin tissue outside the body for extended periods, leveraging AI to identify novel skincare compounds and treatments. This breakthrough approach represents a significant shift in how cosmetic and dermatological innovations are developed and tested.

Polansky's company has been operating in relative secrecy for years, perfecting the technology needed to keep human skin tissue alive in laboratory conditions. The methodology involves maintaining skin samples for weeks outside the body—far longer than previously standard—while using AI algorithms to analyze biological responses and identify promising skincare compounds. By combining bioscience with machine learning, the startup can rapidly screen thousands of potential treatments against actual human tissue, dramatically accelerating the discovery process compared to traditional methods.

This innovation addresses a critical gap in skincare research, where animal testing and synthetic models often fail to replicate authentic human skin responses. The living tissue approach provides researchers with more accurate data while reducing reliance on animal testing.

• Accelerated drug discovery: AI-powered analysis can identify effective compounds in a fraction of the traditional timeline
• Reduced animal testing: Living human tissue models offer ethical alternatives to conventional cosmetic testing methods
• Personalized skincare: The technology may enable customized treatments based on individual skin characteristics
• Lower development costs: Streamlined research processes could reduce expenses for skincare companies
• Regulatory advantages: Human tissue-based data may satisfy regulatory requirements more efficiently than animal studies

This venture exemplifies how AI and biotechnology convergence is transforming healthcare and beauty industries. As consumer demand for ethical, effective skincare grows alongside regulatory pressure to reduce animal testing, innovations like Polansky's offer compelling solutions. The intersection of advanced tissue engineering, artificial intelligence, and skincare science demonstrates how established business leaders are channeling capital into deep-tech solutions addressing real market needs. This development could reshape skincare innovation standards for years to come.